← Leaderboards
Rosa Rademakers
Mayo Clinic Rochester
$18,756,090
Attributed
$19,289,086
Total exposure
11
Grants
11
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $2.8M · FY2009–25$5M$3.8M$2.5M$1.3M$0
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$19,289,086 · 11
By mechanism
R01$5,341,630 · 4
UH3$3,655,415 · 1
U19$3,166,385 · 2
R35$2,893,937 · 1
P50$2,325,306 · 2
UG3$1,906,413 · 1
Top collaborators
- Renzo Mancuso2 shared
Most similar at Mayo Clinic Rochester
Same institution · by research overlap
- Adam L Boxer$75,127,044
- Howard J Rosen$46,265,858
- Keith A Josephs$19,660,217
- William W Seeley$26,843,727
- Jennifer Louise Whitwell$16,907,629
Others in their field
Top investigators on “Pathology”
- Lawrence Corey · Fred Hutchinson Cancer Center$196,976,947
- Glenda E Gray · Wits Health Consortium (Pty), Ltd$196,976,947
- Paul S. Aisen · Cognition Therapeutics, Inc.$155,099,919
- Reisa A. Sperling · Banner Health$154,825,070
- Ronald T Mitsuyasu · University Of California Los Angeles$145,092,412
- Joseph E Robertson · Oregon Health & Science University$126,125,279
Research focus
PathologyNeurodegenerative DisordersVariantGeneticSamplingGenesFrontotemporal Lobar DegenerationsMutationFamilyCohortDesignProtein Tdp-43AffectFunctional DisorderAmyotrophic Lateral SclerosisAlzheimer&AposS DiseaseCollaborationsBrainCollectionPathway InteractionsIn VitroGenome SequencingGenotype
Grant awards (40)
The TMEM106B-GRN-TDP43 triad: leveraging human samples and humanized models to unravel FTLD-TDP disease mechanisms$527,612
R01 · FY2025 · AG · contact PI
Genetics Core$474,553
U19 · FY2025 · AG · contact PI
The TMEM106B-GRN-TDP43 triad: leveraging human samples and humanized models to unravel FTLD-TDP disease mechanisms$538,380
R01 · FY2024 · AG · contact PI
Genetics Core$463,018
U19 · FY2024 · AG · contact PI
Genetics Core$545,434
U19 · FY2023 · AG · contact PI
Whole genome sequencing consortium on Frontotemporal dementia with underlying TDP-43 pathology$1,213,868
UH3 · FY2021 · NS · contact PI
Genetics Core$545,434
U19 · FY2021 · AG · contact PI
Whole genome sequencing consortium on Frontotemporal dementia with underlying TDP-43 pathology$1,213,760
UH3 · FY2020 · NS · contact PI
Genetics Core$545,434
U19 · FY2020 · AG · contact PI
Genetics Core$17,578
U19 · FY2020 · AG · contact PI
Whole genome sequencing consortium on Frontotemporal dementia with underlying TDP-43 pathology$1,227,787
UH3 · FY2019 · NS · contact PI
Genetic Discovery and Pathobiology of Frontotemporal Lobar Degeneration and Related TDP-43 Proteinopathies$1,002,684
R35 · FY2019 · NS · contact PI
Genetics Core$574,934
U19 · FY2019 · AG · contact PI
Genetic Discovery and Pathobiology of Frontotemporal Lobar Degeneration and Related TDP-43 Proteinopathies$1,002,684
R35 · FY2018 · NS · contact PI
Whole genome sequencing consortium on Frontotemporal dementia with underlying TDP-43 pathology$944,944
UG3 · FY2018 · NS · contact PI
Whole genome sequencing consortium on Frontotemporal dementia with underlying TDP-43 pathology$961,469
UG3 · FY2017 · NS · contact PI
Genetic Discovery and Pathobiology of Frontotemporal Lobar Degeneration and Related TDP-43 Proteinopathies$888,569
R35 · FY2017 · NS · contact PI
Molecular genetic studies of progranulin regulators in FTLD and ALS$342,344
R01 · FY2016 · NS · contact PI
Identification of novel Parkinsonian genes by wholegenome$264,284
P50 · FY2016 · NS · contact PI
GGGGCC hexanucleotide repeat expansions in neurodegenerative disease$152,007
R01 · FY2016 · NS · contact PI
GGGGCC hexanucleotide repeat expansions in neurodegenerative disease$364,067
R01 · FY2015 · NS · contact PI
Molecular genetic studies of progranulin regulators in FTLD and ALS$342,344
R01 · FY2015 · NS · contact PI
Identification of novel Parkinsonian genes by wholegenome$299,122
P50 · FY2015 · NS · contact PI
GGGGCC hexanucleotide repeat expansions in neurodegenerative disease$359,705
R01 · FY2014 · NS · contact PI
Molecular genetic studies of progranulin regulators in FTLD and ALS$338,921
R01 · FY2014 · NS · contact PI
Identification of novel Parkinsonian genes by wholegenome$302,260
P50 · FY2014 · NS · contact PI
GGGGCC hexanucleotide repeat expansions in neurodegenerative disease$349,942
R01 · FY2013 · NS · contact PI
Molecular genetic studies of progranulin regulators in FTLD and ALS$342,344
R01 · FY2013 · NS · contact PI
Identification of novel Parkinsonian genes by wholegenome$301,654
P50 · FY2013 · NS · contact PI
THE PGRN/TDP-43 AXIS IN ALZHEIMER?S DISEASE AND NEURODEGENERATION$146,195
P50 · FY2013 · AG · contact PI
GGGGCC hexanucleotide repeat expansions in neurodegenerative disease$361,947
R01 · FY2012 · NS · contact PI
Progranulin: Mutation and Regulation in Neurodegenerative disease$327,994
R01 · FY2012 · NS · contact PI
Identification of novel Parkinsonian genes by wholegenome$314,905
P50 · FY2012 · NS · contact PI
THE PGRN/TDP-43 AXIS IN ALZHEIMER?S DISEASE AND NEURODEGENERATION$170,851
P50 · FY2012 · AG · contact PI
Progranulin: Mutation and Regulation in Neurodegenerative disease$327,994
R01 · FY2011 · NS · contact PI
THE PGRN/TDP-43 AXIS IN ALZHEIMER?S DISEASE AND NEURODEGENERATION$168,845
P50 · FY2011 · AG · contact PI
Progranulin: Mutation and Regulation in Neurodegenerative disease$331,341
R01 · FY2010 · NS · contact PI
THE PGRN/TDP-43 AXIS IN ALZHEIMER?S DISEASE AND NEURODEGENERATION$177,293
P50 · FY2010 · AG · contact PI
Progranulin: Mutation and Regulation in Neurodegenerative disease$334,688
R01 · FY2009 · NS · contact PI
THE PGRN/TDP-43 AXIS IN ALZHEIMER?S DISEASE AND NEURODEGENERATION$179,897
P50 · FY2009 · AG · contact PI